J&J Procrit Pricing Practices Stabilize Sales, Position Product For Rebound
Executive Summary
J&J pricing strategies have stabilized Procrit sales, possibly positioning the struggling franchise for a rebound, CEO William Weldon stated
You may also be interested in...
J&J Open To Large-Scale Mergers; Still Prefers Centocor, Alza-Sized Deals
Johnson & Johnson is open to deals larger than the $10.5 bil. Alza acquisition, CEO William Weldon said Jan. 20
J&J Open To Large-Scale Mergers; Still Prefers Centocor, Alza-Sized Deals
Johnson & Johnson is open to deals larger than the $10.5 bil. Alza acquisition, CEO William Weldon said Jan. 20
J&J Topamax “Dear Doctor” Letter Advises Metabolic Acidosis Monitoring
Physicians should periodically examine Topamax (topiramate) patients for metabolic acidosis, a Johnson & Johnson "Dear Health Care Professional" letter recommends